Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 29,858,868	$ 3,322,226
Accounts receivable, net	158,837	125,790
Inventory, net	146,879	131,378
Other current assets	868,842	284,115
Total current assets	31,033,426	3,863,509
Property and equipment, at cost:
Leasehold improvements	1,155,332	1,155,332
Office equipment	64,145	64,145
Furniture and fixtures	424,947	424,947
Machinery and equipment	2,242,088	2,242,088
Construction in progress	151,662	139,150
Property and equipment, Gross	4,038,174	4,025,662
Less accumulated depreciation	(2,470,397)	(2,197,868)
Net property and equipment	1,567,777	1,827,794
Long-term assets:
Lease right-of-use assets, net	854,817	1,057,506
Intangible assets, net of accumulated amortization	42,185	65,069
Other long-term assets	488,961	792,440
Total long-term assets	1,385,963	1,915,015
Total assets	33,987,166	7,606,318
Current liabilities:
Accounts payable	947,078	674,333
Accrued expenses	430,183	1,117,601
Clinical holdback - current portion	18,947	0
Notes payable - current portion	470,556	630,010
Lease liabilities - current portion	419,333	434,072
Other - current	32,895	32,895
Total current liabilities	2,318,992	2,888,911
Long-term liabilities:
Clinical holdback - long-term portion	151,958	164,972
Note payable - long-term portion	0	182,490
Lease liabilities - long-term portion	603,616	809,092
Other - long-term	32,895	32,895
Total long-term liabilities	788,469	1,189,449
Total liabilities	3,107,461	4,078,360
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $.001 par, 200,000,000 authorized, 11,916,943 shares issued and 11,799,720 outstanding as of June 30, 2021; and 95,583,558 authorized, 1,110,347 shares issued and 993,124 outstanding as of December 31, 2020	11,916	1,110
Treasury stock, 117,223 shares	(60,000)	(60,000)
Warrants	702,492	702,492
Additional paid-in-capital	108,341,078	22,725,949
Accumulated deficit	(78,115,781)	(75,202,490)
Total stockholders' equity (deficit)	30,879,705	(51,815,728)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)	33,987,166	7,606,318
Series B Preferred Stock [Member]
Redeemable convertible preferred stock:
Preferred stock	0	10,748,873
Series C Preferred Stock [Member]
Redeemable convertible preferred stock:
Preferred stock	0	44,594,813
Series A Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock, Series A, $.001 par, none authorized, issued and outstanding as of June 30, 2021; 17,310,609 shares authorized, and 17,210,609 shares issued and outstanding as of December 31, 2020	$ 0	$ 17,211